Charles River Laboratories Intl. Inc vs Wells Fargo & Co — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while Wells Fargo & Co trades at $87.35 (market cap $264.66B). The key difference: Wells Fargo & Co is far larger — about 19.7× Charles River Laboratories Intl. Inc's market cap, and Wells Fargo & Co pays a 2.29% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | WFC | |
|---|---|---|
Market Cap | $13.46B | $264.66B |
Sector | Health | Financials |
52-Week High | $282.00 | $96.40 |
52-Week Low | $145.57 | $73.42 |
Enterprise Value | $16.30B | — |
Dividend Yield | — | 2.29% |
Trailing returns across standard periods
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →